1.Progress of antibiotic-loaded bone cement in joint arthroplasty.
Yi-Ming XU ; Hui-Ming PENG ; Bin FENG ; Xi-Sheng WENG
Chinese Medical Journal 2020;133(20):2486-2494
Bone cement, consisting of polymethyl methacrylate, is a bioinert material used for prothesis fixation in joint arthroplasty. To treat orthopedic infections, such as periprosthetic joint infection, antibiotic-loaded bone cement (ALBC) was introduced into clinical practice. Recent studies have revealed the limitations of the antibacterial effect of ALBC. Moreover, with the increase in high infection risk patients and highly resistant microbes, more researches and modification of ALBC are required. This paper reviewed latest findings about ALBC for most popular and destructive pathogens, summarized the influence of antibiotic kind, drug dosage, application method, and environment towards characteristic of ALBC. Subsequently, new cement additives and clinical applications of ALBC in joint arthroplasty were also discussed.
Anti-Bacterial Agents/therapeutic use*
;
Arthroplasty, Replacement, Knee
;
Bone Cements
;
Humans
;
Polymethyl Methacrylate
;
Prosthesis-Related Infections/drug therapy*
2.Integrated Chinese and Western Medicine in Treatment of Critical Coronavirus Disease (COVID-19) Patient with Endotracheal Intubation: A Case Report.
Shun-Yu YAO ; Chao-Qi LEI ; Xiang LIAO ; Ru-Xiu LIU ; Xing CHANG ; Zhi-Ming LIU
Chinese journal of integrative medicine 2021;27(4):300-303
Adult
;
Anti-Bacterial Agents/therapeutic use*
;
COVID-19/drug therapy*
;
Catheter-Related Infections/microbiology*
;
China
;
Drug Resistance, Multiple, Bacterial
;
Drugs, Chinese Herbal/therapeutic use*
;
Humans
;
Intubation, Intratracheal
;
Male
;
Pneumonia, Viral/drug therapy*
;
Prosthesis-Related Infections/microbiology*
;
SARS-CoV-2
3.Comprehensive meta-analysis of antibiotic-impregnated bone cement versus plain bone cement in primary total knee arthroplasty for preventing periprosthetic joint infection.
Ting XU ; Ke-Liang WU ; Ke JIE
Chinese Journal of Traumatology 2022;25(6):325-330
PURPOSE:
Antibiotic-loaded bone cement (ALBC) was usually used to prevent periprosthetic joint infection (PJI) in primary total knee arthroplasty (PTKA), but whether to use ALBC or plain bone cement in PTKA remains unclear. We aimed to compare the occurrence rate of PJI using two different cements, and to investigate the efficacy of different antibiotic types and doses administered in preventing surgical site infection (SSI) with ALBC.
METHODS:
The availability of ALBC for preventing PJI was evaluated by using a systematic review and meta-analysis referring to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Existing articles until December 2021 involving PTKA patients with both ALBC and plain bone cement cohorts were scanned by searching "total knee arthroplasty", "antibiotic-loaded cement", "antibiotic prophylaxis", "antibiotic-impregnated cement" and "antibiotic-laden cement" in the database of PubMed/MEDLINE, Embase, Web of Science and the Cochrane Library. Subgroup analysis included the effectiveness of different antibiotic types and doses in preventing SSI with ALBC. The modified Jadad scale was employed to score the qualities of included articles.
RESULTS:
Eleven quantitative studies were enrolled, including 34,159 knees undergoing PTKA. The meta-analysis results demonstrated that the use of prophylactic ALBC could significantly reduce the prevalence of deep incisional SSI after PTKA, whereas there was no significant reduction in the rate of superficial incisional SSI. Moreover, gentamicin-loaded cement was effective in preventing deep incisional SSI, and the use of high-dose ALBC significantly reduced the rate of deep incisional SSI after PTKA. Besides, no significant adverse reactions and complications were stated during the use of ALBC in PTKA.
CONCLUSION
The preventive application of ALBC during PTKA could reduce the rates of deep PJI. Furthermore, bone cement containing gentamicin and high-dose ALBC could even better prevent deep infection after PTKA. However, the existing related articles are mostly single-center and retrospective studies, and further high-quality ones are needed for confirmation.
Humans
;
Bone Cements
;
Arthroplasty, Replacement, Knee/methods*
;
Anti-Bacterial Agents/therapeutic use*
;
Prosthesis-Related Infections/etiology*
;
Retrospective Studies
;
Arthritis, Infectious/etiology*
;
Gentamicins
;
Surgical Wound Infection/drug therapy*
4.Mixed bacterial-fungal infection following total hip arthroplasty: A case report.
Yang-Jing LIN ; Tiao SU ; Liu YANG ; Guang-Xing CHEN
Chinese Journal of Traumatology 2022;25(1):32-36
Prosthetic infection is one of the severe postoperative complications of arthroplasty. Mixed bacterial-fungal prosthetic infection is rare but can be disastrous. This case was a 76-year-old female suffered from prosthetic infection following total hip replacement due to femoral neck fracture and underwent multiple debridements. The culture of periprosthetic tissue was bacteriologically sterile following the first debridement, while the Staphylococcus hominis was identified in the second debridement in the previous hospitalization where fungal infection had not been considered. Thus the pathogen spectrum of anti-infection therapy failed to contain fungus. Ultimately, the culture result of our sampled periprosthetic tissue during the third debridement was Candida albicans without bacterium in our hospital. The fungal prosthetic infection was successfully treated by a two-stage revision with antifungal drugs. Accurate diagnosis and standardized treatment is the key to the therapy of infection after hip arthroplasty, especially for mixed bacterial-fungal prosthetic infection.
Aged
;
Anti-Bacterial Agents/therapeutic use*
;
Arthroplasty, Replacement, Hip/adverse effects*
;
Debridement
;
Female
;
Fungi
;
Hip Prosthesis/adverse effects*
;
Humans
;
Mycoses/drug therapy*
;
Prosthesis-Related Infections/therapy*
;
Reoperation
;
Retrospective Studies
;
Treatment Outcome
5.Clinical study on second-stage revision in the postoperative infection after total hip replacement.
Yi-Long DONG ; Guo-Jing YANG ; Rui-Xin LIN
China Journal of Orthopaedics and Traumatology 2010;23(3):194-196
OBJECTIVETo study the therapeutic effects and clinical experiences of second-stage revision in postoperative infection after total hip replacement and to explore its security and validity.
METHODSFrom January 2006 to March 2009, 17 hips in 17 patients (7 males and 10 females, ranging in age from 43 to 75 years, with an average of 58.5 years) were treated with second-stage revision. All the patients suffered from different degrees of hip pain. In bacilliculture of Synovial fluid or peritonsillar tissue, 11 patients showed positive results and 6 patient negative. The intraoperative periprosthetic histopathological examination showed that all the patients had acute inflammation. Eight patients had sinus communicating with prosthesis; 15 patients had increased ESR, and 15 patients had C reactive protein increased. All the patients had osteolysis, prosthesis loosening, and the performance of periosteal reaction in X-ray. All the patients were treated with second stage revision. In the first operation, thorough debridement was perfumed and the prosthesis was removed. Then the prosthesis of antibiotic--loaded acrylic cement was implanted. After giving antibiotics intravenously for 4 weeks, the antibiotics were taken orally for another six weeks. The ESR and C response protein were examined at regular time, and the second-stage revision surgery was perfumed when the ESR and C response protein were normal. The Harris score was used to evaluate therapeutic effects of second-stage revision surgery before and after treatment.
RESULTSAll the patients were followed up with an average of 19.5 months, ranged from 12 to 35 months. No complications occurred. Postoperative X-ray showed prosthesis in the correct position. The Harris score increased from preoperative (39.3 +/- 5.6) to postoperative (84.4 +/- 10.3) (t = 15.86, P < 0.01).
CONCLUSIONThe second-stage revision in postoperative infection after total hip replacement has a good efficacy, safety and reliability advantages. This technology provides an alternative in postoperative infection after total hip replacement.
Adult ; Aged ; Anti-Bacterial Agents ; therapeutic use ; Arthroplasty, Replacement, Hip ; adverse effects ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Postoperative Complications ; drug therapy ; microbiology ; surgery ; Prosthesis-Related Infections ; drug therapy ; microbiology ; surgery
6.In vitro antimicrobial effects of grape seed extract on peri-implantitis microflora in craniofacial implants.
Binit SHRESTHA ; M L Srithavaj THEERATHAVAJ ; Sroisiri THAWEBOON ; Boonyanit THAWEBOON
Asian Pacific Journal of Tropical Biomedicine 2012;2(10):822-825
OBJECTIVETo determine the antimicrobial effects of grape seed on peri-implantitis microflora.
METHODSThe grape seed extract was tested against peri-implantitis microflora most commonly found in craniofacial implants including reference strains of Staphylococcus aureus (S. aureus), Escherichia coli (E. coli), Candida albicans (C. albicans) and clinical strains of S. aureus, Klebsiella pneumonia (K. pneumonia) and Candida parapsilosis (C. parapsilosis) by disk diffusion test. Minimum inhibitory concentrations (MIC) and minimum cidal concentrations (MCC) were determined using modified agar dilution millpore method. The extract was further combined with polyethylene glycol and propylene glycol, and was tested for antimicrobial effects.
RESULTSGrape seed extract showed positive inhibitory effects with S. aureus at MIC of 0.625 mg/mL and MCC of 1.25 mg/mL respectively. However the extracts showed minimal or no reactivity against strains of E. coli, K. pneumonia, C. parapsilosis and C. albicans. The use of grape seed extract in combination with polyethylene glycol and propylene glycol also showed dose dependent inhibitory effect on S. aureus.
CONCLUSIONSThe results of the study showed that grape seed has potential antimicrobial effects which can be further studied and developed to be used in the treatment of infected skin-abutment interface of craniofacial implants.
Anti-Infective Agents ; pharmacology ; Bacteria ; drug effects ; Craniofacial Abnormalities ; surgery ; Disk Diffusion Antimicrobial Tests ; Grape Seed Extract ; pharmacology ; Humans ; Microbial Sensitivity Tests ; Prostheses and Implants ; adverse effects ; Prosthesis-Related Infections ; drug therapy ; microbiology
7.Updates in penile prosthesis infections.
Amanda R SWANTON ; Ricardo M MUNARRIZ ; Martin S GROSS
Asian Journal of Andrology 2020;22(1):28-33
Inflatable penile prostheses are an important tool in the treatment of medically refractory erectile dysfunction. One of the major complications associated with these prostheses is infections, which ultimately require device explanation and placement of a new device. Over the past several decades, significant work has been done to reduce infection rates and optimize treatment strategies to reduce patient morbidity. This article reviews the current state of knowledge surrounding penile prosthesis infections, with attention to the evidence for methods to prevent infection and best practices for device reimplantation.
Anti-Bacterial Agents/therapeutic use*
;
Anti-Infective Agents, Local/therapeutic use*
;
Antibiotic Prophylaxis/methods*
;
Bandages
;
Carrier State/drug therapy*
;
Chlorhexidine/therapeutic use*
;
Coated Materials, Biocompatible
;
Device Removal
;
Diabetes Mellitus/epidemiology*
;
Erectile Dysfunction/surgery*
;
Gram-Negative Bacterial Infections/therapy*
;
Hair Removal/methods*
;
Humans
;
Immunocompromised Host/immunology*
;
Male
;
Penile Implantation/methods*
;
Penile Prosthesis
;
Preoperative Care/methods*
;
Prosthesis-Related Infections/therapy*
;
Reoperation
;
Risk Factors
;
Spinal Cord Injuries/epidemiology*
;
Staphylococcal Infections/therapy*
;
Staphylococcus aureus
;
Staphylococcus epidermidis
;
Surgical Drapes
;
Surgical Instruments
;
Surgical Wound Infection/therapy*
8.Re-evaluation of transvenous lead extraction with modified standard technique: a prospective study in 229 patients.
Xian-Ming CHU ; Xue-Bin LI ; Ping ZHANG ; Long WANG ; Ding LI ; Jiang-Bo DUAN ; Bing LI ; Ji-Hong GUO
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(5):650-655
As new-type powered sheaths are expensive and unavailable, the standard lead extraction techniques remain the mainstay in clinical applications in many countries. The purpose of this study was to re-evaluate the clinical application of the standard lead extraction techniques and equipment, and make some procedural modifications and innovations. In our center, between January 2006 and May 2012, 229 patients (median, 66 years) who underwent lead extraction due to infection and lead malfunction were registered and followed up prospectively with respect to clinical features, reasons for lead extraction, technical characteristics, and clinical prognosis. A total of 440 leads had to be extracted transvenously by using special tools from 229 patients (male, 72.1%). Vegetations ≥1 cm were detected in six patients. Locking Stylets were applied for 398 (90.5%) leads. Telescoping dilator polypropylene sheaths and counter traction technique were used for 202 (45.9%) leads due to lead adhesion, and the mean implant duration of the 202 leads was longer than the other 238 leads (48.9±22.6 vs. 26.6±17.8 months; P <0.01). In addition, modified isolation and snare techniques were used for 56 leads (12.7%). Minor and major procedure-related complications occurred in three (1.3%) and four (1.7%) cases respectively, including one death (0.4%). Severe lead residue occurred in one case. Complete procedural success rate was 96.1% (423/440), and clinical success rate was 98.9% (435/440). The median follow-up period was 18 (1-76) months. No infection- and procedure-related death occurred in our series. Our data demonstrated that high clinical success rate of transvenous lead extraction can be guaranteed by making full use of the standard lead extraction techniques and equipment with individualized modifications.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Anti-Bacterial Agents
;
therapeutic use
;
Child
;
Child, Preschool
;
Device Removal
;
methods
;
Electrodes, Implanted
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Middle Aged
;
Pacemaker, Artificial
;
Prospective Studies
;
Prosthesis-Related Infections
;
drug therapy
;
surgery
;
Treatment Outcome
;
Young Adult